Literature DB >> 29654545

Cognitive Impairments and Subjective Cognitive Complaints in Fabry Disease: A Nationwide Study and Review of the Literature.

Josefine Loeb1, Ulla Feldt-Rasmussen1, Christoffer Valdorff Madsen1, Asmus Vogel2,3.   

Abstract

Fabry disease is a rare progressive X-linked lysosomal storage disorder which leads to neuropathic pain, organ dysfunction and cerebral pathology. Few studies have investigated cognitive impairment in Fabry disease and these previous studies are difficult to compare due to heterogeneous methodological designs and small cohorts. The objective was to investigate the frequency of cognitive impairment in the Danish nationwide cohort of Fabry patients. Further, we examined if subjective cognitive complaints were associated with objective cognitive performances in this patient group. Neuropsychological tests (17 measures) and evaluation of subjective complaints with the Perceived Deficits Questionnaire (PDQ) were applied in 41 of 63 patients. According to an a priori definition, 12 patients (29.3%) were cognitively impaired. Tests tapping psychomotor speed, attention and executive functions had the highest frequency of impairment. In general, disease related variables as Mainz Severity Score Index, enzyme activity and years since onset and depression did not have a significant impact on the categorisation of patients as being cognitively impaired or non-impaired. Thus, cognitive impairment in Fabry disease does not seem to occur solely by having symptoms for many years or by having high disease burden. However, impaired neuropsychological test results were significantly more common in patients with cerebrovascular disease. Only three patients had scores in the abnormal range of the PDQ scale and subjective perceptions of cognition were not associated with cognitive performances. The levels of subjective cognitive complaints were generally very low in the studied patients demonstrating that the absence of subjective cognitive complaints does not exclude the presence of objective cognitive problems.

Entities:  

Keywords:  Cognition; Fabry disease; Memory; Neuropsychology; Subjective symptoms

Year:  2018        PMID: 29654545      PMCID: PMC6122045          DOI: 10.1007/8904_2018_103

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  25 in total

1.  X-chromosome inactivation in female patients with Fabry disease.

Authors:  L Echevarria; K Benistan; A Toussaint; O Dubourg; A A Hagege; D Eladari; F Jabbour; C Beldjord; P De Mazancourt; D P Germain
Journal:  Clin Genet       Date:  2015-06-22       Impact factor: 4.438

2.  Cognitive function in adults aging with fabry disease: a case-control feasibility study using telephone-based assessments.

Authors:  Virginia G Wadley; Leslie A McClure; David G Warnock; Caroline L Lassen-Greene; Robert J Hopkin; Dawn A Laney; Virginia M Clarke; Manjula Kurella Tamura; George Howard; Katherine Sims
Journal:  JIMD Rep       Date:  2015-01-08

3.  Evaluating storage, retention, and retrieval in disordered memory and learning.

Authors:  H Buschke; P A Fuld
Journal:  Neurology       Date:  1974-11       Impact factor: 9.910

4.  Psychiatric and cognitive profile in Anderson-Fabry patients: a preliminary study.

Authors:  Perri Segal; Yoav Kohn; Yehuda Pollak; Gheona Altarescu; Esti Galili-Weisstub; Annick Raas-Rothschild
Journal:  J Inherit Metab Dis       Date:  2010-06-15       Impact factor: 4.982

5.  Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease.

Authors:  Thaneas Prabakaran; Henrik Birn; Bo M Bibby; Axel Regeniter; Søren S Sørensen; Ulla Feldt-Rasmussen; Rikke Nielsen; Erik I Christensen
Journal:  Nephrol Dial Transplant       Date:  2013-11-08       Impact factor: 5.992

Review 6.  Cognitive dysfunction and depression in Fabry disease: a systematic review.

Authors:  Fay E Bolsover; Elaine Murphy; Lisa Cipolotti; David J Werring; Robin H Lachmann
Journal:  J Inherit Metab Dis       Date:  2013-08-16       Impact factor: 4.982

7.  Cognitive testing in Fabry disease: pilot using a brief computerized assessment tool.

Authors:  Deborah Elstein; Glen M Doniger; Gheona Altarescu
Journal:  Isr Med Assoc J       Date:  2012-10       Impact factor: 0.892

8.  Neurology of Fabry disease.

Authors:  M Low; K Nicholls; N Tubridy; P Hand; D Velakoulis; L Kiers; P Mitchell; G Becker
Journal:  Intern Med J       Date:  2007-07       Impact factor: 2.048

Review 9.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

10.  A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington's disease.

Authors:  Tua Vinther-Jensen; Ida U Larsen; Lena E Hjermind; Esben Budtz-Jørgensen; Troels T Nielsen; Anne Nørremølle; Jørgen E Nielsen; Asmus Vogel
Journal:  Orphanet J Rare Dis       Date:  2014-07-17       Impact factor: 4.123

View more
  5 in total

1.  Predictors of objective cognitive impairment and subjective cognitive complaints in patients with Fabry disease.

Authors:  Simon Körver; Gert J Geurtsen; Carla E M Hollak; Ivo N van Schaik; Maria G F Longo; Marjana R Lima; Leonardo Vedolin; Marcel G W Dijkgraaf; Mirjam Langeveld
Journal:  Sci Rep       Date:  2019-01-17       Impact factor: 4.379

2.  The Mini Mental State Examination does not accurately screen for objective cognitive impairment in Fabry Disease.

Authors:  Simon Körver; Sara A J van de Schraaf; Gert J Geurtsen; Carla E M Hollak; Ivo N van Schaik; Mirjam Langeveld
Journal:  JIMD Rep       Date:  2019-05-20

3.  Neuropsychiatric Symptoms and Their Association With Sex, Age, and Enzyme Replacement Therapy in Fabry Disease: A Systematic Review.

Authors:  Magdalena Mroczek; Ignazio Maniscalco; Manon Sendel; Ralf Baron; Erich Seifritz; Albina Nowak
Journal:  Front Psychiatry       Date:  2022-03-16       Impact factor: 4.157

4.  Structural disconnection and functional reorganization in Fabry disease: a multimodal MRI study.

Authors:  Ilaria Gabusi; Giuseppe Pontillo; Maria Petracca; Matteo Battocchio; Sara Bosticardo; Teresa Costabile; Alessandro Daducci; Chiara Pane; Eleonora Riccio; Antonio Pisani; Arturo Brunetti; Simona Schiavi; Sirio Cocozza
Journal:  Brain Commun       Date:  2022-07-22

5.  Cognitive functioning and depressive symptoms in Fabry disease: A follow-up study.

Authors:  Simon Körver; Gert J Geurtsen; Carla E M Hollak; Ivo N van Schaik; Maria G F Longo; Marjana R Lima; Marcel G W Dijkgraaf; Mirjam Langeveld
Journal:  J Inherit Metab Dis       Date:  2020-06-25       Impact factor: 4.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.